William J. Peters - 30 Dec 2021 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Role
CFO, EVP & Treasurer
Signature
/s/ William J. Peters
Issuer symbol
AMPH
Transactions as of
30 Dec 2021
Net transactions value
-$90,000
Form type
4
Filing time
04 Jan 2022, 15:52:16 UTC
Previous filing
22 Dec 2021
Next filing
11 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPH Common Stock Options Exercise $144,000 +10,000 +9.4% $14.40 116,042 30 Dec 2021 Direct
transaction AMPH Common Stock Sale $234,000 -10,000 -8.6% $23.40 106,042 30 Dec 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPH Employee Stock Option (right to buy) Options Exercise $0 -10,000 -9.2% $0.000000 98,553 30 Dec 2021 Common Stock 10,000 $14.40 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 7, 2021.
F2 Shares subject to the option are fully vested and immediately exercisable.